Bone morphogenetic proteins (BMPs) are members of the TGFβ-family of signaling proteins and play an important role during development and in tissue formation. BMP signaling is a well studied process, which is initiated through binding of cognate receptors and processed via activation of Smad downstream mediators. A hallmark of BMP signaling is its modulation on the extracellular level through specific antagonists.
Introduction
Bone morphogenetic proteins (BMPs) are cytokines that are expressed at all developmental stages and are important regulators of embryogenesis, patterning, organogenesis and finally tissue homeostasis in adults (Chen et al., 2004) . The latter is reflected by dysregulated BMP signaling in pathological processes, e.g. cancer development and tissue fibrosis (Clement and Wölfl, 2004; Thawani et al., 2010; Denecke et al., 2010) .
Because of their general importance, thorough investigations have led to considerable knowledge about the mechanisms of BMP signaling in organisms and in target cells (Schmierer and Hill, 2007) . On the cellular level, BMP signaling starts with BMP binding to type I and type II cognate receptors forming heterotetrameric complexes, which leads to phosphorylation of intracellular receptor-activated (R)-Smads (Smad1, 5 and 8).
Subsequently, activated R-Smads associate with the shared interaction partner (co-)Smad (Smad4) and translocate into the nucleus, where they bind cognate DNA motives and recruit transcriptional co-activators and co-repressors to control gene expression (Rosenzweig et al. 1995 , Schmierer and Hill, 2007 , Hill, 2009 , Sieber, 2009 ). The first step, BMP ligand-receptor interaction can be inhibited by extracellular modulator proteins such as Noggin, Chordin and Gremlin (Groppe et al., 2002; Sasai et al., 1994; Merino et al., 1999) . In fact, interactions between BMPs and BMP-antagonists at the extracellular level are a hallmark of the BMP signaling network (Umulis et al., 2009 , Walsh et al., 2010 .
Endocytosis via clathrin-mediated internalization pathways is a major regulatory mechanism for many plasma membrane receptors. It had been shown that BMP-receptors are internalized through clathrin as well as caveolin dependent mechanisms (Hartung et al., 2006) . Interestingly, phosphorylation of Smad1 and 5 occurred independently of receptor internalization, while activation of Smad-independent downstream signals may require receptor internalization (Hartung et al., 2006) . In these experiments, it remained open whether the BMP ligand is internalized as well. In some more recent publications, internalization of BMPs was shown after longer incubation (Kelley et al., 2009 , von Einem et al., 2011 . To address this question in more detail, we prepared a biologically active fluorescently labeled recombinant BMP2. With such labeled BMP2 ligands, we Journal of Cell Science Accepted manuscript 4 were able to visualize and quantitatively measure BMP2 internalization, and follow BMP2 uptake over time. Ligand internalization was measured in single cells using high resolution confocal microscopy and flow cytometry (FACS). Automated image processing was used to quantify microscopic images on the level of single endosomes (Schmidt-Glenewinkel et al., 2009) . Thereby, various endosome parameters could be defined, which were used to evaluate the temporal evolution of endosomes during BMP2 endocytosis. Fluorescently labeled BMP2 internalization was also disturbed by cotreatment with different BMP antagonists, such as Noggin, Gremlin, Chordin, and the small molecule inhibitor dorsomorphin. Furthermore, using inhibitors of specific endocytotic pathways, we could specify that BMP2 endocytosis occurs through a clathrin dependent process.
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Results
Labeling of recombinant BMP2 with a fluorescent dye yields biologically active
BMP2
Aiming to generate a tool for tracking BMP2 uptake in cells with fluorescent confocal microscopy and flow cytomery (Fig. 1) , recombinant human BMP2 was labeled with fluorescent dyes. Among others, FITC and DyLight (Thermo Scientific), as described in detail in Materials and Methods, were used as dyes. Labeled proteins were separated from unbound dyes with Zeba TM desalt spin columns (Thermo Scientific). Our optimised reaction conditions resulted in complete labelling of BMP2 at N-terminal residues. The position of dye was mapped by mass spectroscopy, although a precise location could not be determined. Complete N-terminal labelling was further confirmed using native PAGE and western blot analysis with a BMP2-specific antibody that recognizes the 14 Nterminal residues of mature BMP2 (BMP2(N-14), Santa Cruz Biotechnology: sc-6895).
While this antibody clearly detects non-labeled BMP2, fluorescently labeled BMP2 is not detected which can be explained by interference with antibody binding (Fig. 2 A, B ). This result also confirms that purified FL-BMP2 did not contain detectable levels of unlabeled BMP2.
To ensure that fluorescently labeled BMP2 retained its physiological activity, activation of downstream BMP2 signaling was tested in HeLa cells analyzing Smad1/5/8 phosphorylation and induction of a BRE-luciferase reporter gene (Korchynskyi et al., 2002 (Fig. 3A) shows a clear shift in mean intensity upon FL-BMP2 uptake from 1 h to 12 h incubation.
These results are also presented in Fig. 3B (upper line) clearly visualizing that uptake continuously increased over time with a smaller increase at the beginning.
In the second approach, FL-BMP2 was added as described above, but unbound FL-BMP2 was removed after 1 h by washing with PBS before further incubation in fresh medium.
Fluorescence of cells was analyzed at the same time points and also with protease treatment before FACS analysis for visualization of internalized FL-BMP2 only (Fig. 3B , lower line). The results show a clear but slight increase until the 6 h time-point. Thus, ligands bound to the cell surface during FL-BMP2 exposure (1 h) were still internalized in this period. To further elucidate uptake immediately after exposure to FL-BMP2 we also included measurements after 5, 10, 15, 20, 25 and 30 min of incubation using the first protocol (Fig. 3C) . Interestingly, no significant internalization could be detected when cells were treated with protease before FACS analysis within the first 30 min of
To also analyze surface bound labeled BMP2 in FACS measurements, we developed a third experimental approach. In this setup, cells were maintained in a single cell suspension by an artificial peptide matrix. Cells from such suspension culture can be directly analyzed by FACS without protease treatment. Therewith, both surface bound and internalized BMP2 were detected and showed no significant difference at 5 min and 1 h of incubation with FL-BMP2 (Fig. 3D) . 
Parameterized characterization of endosomal vesicles
In order to obtain a more detailed and quantitative analysis of the FL-BMP2 trafficking process, microscopic images were segmented, and subsequently population-as well as single endosome-parameters were detected (Fig. 4 , and Materials and Methods): i) the number of endosomes per cell; ii) endosome size; iii) endosome distance to the nucleus; and iv) endosome dispersal (i.e. the median of all pair-wise distances of an endosome).
We found that the number of vesicles increased constantly and continuously, suggesting that BMP2 endocytosis is a continuous process (Fig. 5A) . Further, the size of vesicles increased over time ( , 2004) . Interestingly, these morphological changes were accompanied by spatial relocation of endosomes towards the cell interior. A decreased mean distance to the nucleus over time suggests that the endosome population shifts from the periphery towards the perinuclear region of the cell (Fig. 5C ). Moreover, endosomes cluster together as they approach the perinuclear region, as indicated by a reduced mean dispersal (Fig. 5D ).
To ensure that intact FL-BMP2 and not free fluorescent dye is analyzed, cell lysates were subjected to gel electrophoresis resolving FL-BMP2 and, if present, free dye. The results
show that FL-BMP2 remained intact in the time frame analyzed (Supp. Fig. 1 ).
Effect of physiological BMP antagonists on BMP2 uptake in HeLa cells
Activity of BMP2 is controlled by various BMP antagonists, including Noggin, Gremlin, and Chordin (Groppe et al., 2002; Sasai et al., 1994; Merino et al., 1999) . Thus, we wanted to address the question, if these antagonists influence BMP2 binding and uptake.
For this we co-incubated HeLa cells with FL-BMP2 and one of the antagonist for 6 and 24 h. Co-treatment of FL-BMP2 with Noggin and Gremlin significantly increased FL-BMP2 uptake (Fig. 6A ). In contrast, adding Chordin reduced internalization of FL-BMP2.
We also tested the effect of heparinase III on FL-BMP2 internalization, since it had been suggested that heparansulfate proteoglycans may play a role in BMP2 signaling (Jiao et al., 2007; Kuo et al., 2010) . Co-treatment with heparinase III significantly reduced BMP2 endocytosis ( Fig. 6A ). Heparinase III treatment also reduced the uptake of FL-BMP2 in presence of Noggin, but did not fully abolish the Noggin mediated increase (Fig. 6B ).
These results confirm that cell surface proteoglycans play a role in BMP2 binding (Kuo et al., 2010) .
We next analyzed if the observed effects of BMP antagonists are dose-dependent ( Fig.   6C ). Increasing the amount of Noggin from 2× to 10× (relative ratio to BMP2) led to a continuous increase of FL-BMP2 uptake. Increasing concentrations of Gremlin, from 2×
to 5× showed a similar concentration dependent effect, while at a 10× ratio of Gremlin to FL-BMP2, BMP2 uptake was significantly lower compared to 2× and 5× concentrations of Gremlin but still slightly higher when compared to control without antagonist.
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The effect of Noggin on of FL-BMP2 internalization was also analyzed in an independent experiment using high resolution microscopy and quantitative image analysis (Fig. 6D , E). Co-treatment with Noggin leads to a significant increase in fluorescence of endosomal particles after 12 h, which is in good agreement with FACS measurements.
To ensure that the BMP antagonist used not only influence internalization but were also efficiently inhibiting BMP2 signaling, we analyzed Smad1/5/8 activation in response to FL-BMP2 treatment with and without the respective extracellular antagonists. All BMP antagonist used, Noggin, Gremlin, Chordin clearly reduced Smad1/5/8 phosphorylation albeit to a different extent (Fig. 6F ).
In addition to the physiological extracellular BMP2 antagonists, we also used the small molecule BMP receptor type I inhibitor, dorsomorphin (Yu et al., 2008) . At earlier time points (3 and 6 h), co-treatment with dorsomorphin slightly decreased FL-BMP2 uptake ( 
BMP-receptor 1a expression level influences BMP2 uptake
To address the question if specific BMP-receptors may be involved in BMP-ligand uptake, cells were transfected with a BMPR1a expression plasmid to increase the level of BMPR1a expression. Comparing FL-BMP2 uptake in wild-type and BMPR1a overexpressing cells after 6 h incubation with FL-BMP2, a clear increase of FL-BMP2 uptake upon overexpression of BMPR1a was observed (Fig 7A,B) . Interestingly, no significant change of endogenous BMPR1a was observed during treatment of wild-type cells with FL-BMP2 alone or upon co-incubation of FL-BMP2 with inhibitors ( Fig 7C) .
BMP2 is internalized through a clathrin-dependent mechanism
It has been suggested that BMPR1a is internalized by two distinct mechanisms associated with specific BMP-signaling pathways (Hartung et al., 2006) . Looking directly at the Journal of Cell Science Accepted manuscript receptor, they concluded that canonical Smad1/5/8-signaling occurred through preformed BMPR1 and BMPR2 complexes which are internalized after ligand binding through clathrin coated pits, while BMP receptors internalized through caveolin dependent mechanisms were associated with cholesterol enriched lipid rafts and Smad independent signals (Hartung et al., 2006) . This study did not analyze whether receptor endocytosis by one or the other mechanism occurred with or without BMP2-ligand.
To identify which of these mechanisms mediated the observed BMP2-ligand internalization, we pre-incubated cells for 30 min with chlorpromazine, a pharmacological compound blocking clathrin-mediated endocytosis, or alternatively with genistein, which prevents caveolin-mediated uptake by blocking cav-1 phosphorylation (Aoki et al. 1999; Sharma et al. 2004; Ma et al. 2011 ). Both inhibitors differently reduced FL-BMP2 internalization (Fig. 8A ). Chlorpromazine reduced FL-BMP2 uptake at all time points, to a lesser extent at 3 h and more clearly after 6 and 12 h. Upon treatment with genistein, reduced uptake was only clearly visible after 12 h. At this time point the inhibition of uptake by genistein could be a secondary effect not related to caveolin mediated internalization but rather result from the tyrosine kinase inhibitor activity of genistein (Aoki et al. 1999 , Ma et al. 2011 ). Co-incubation with both inhibitors showed an additive effect on FL-BMP2 internalization at the 12 h time point, indicating complementary activity after this extended incubation (Fig. 8A ). It should be noted that we also observed inhibition of BMP2-internalization in C2C12 myoblasts by chlorpromazine (data not shown), confirming that clathrin-mediated endocytosis of the BMP-ligand is a cell type independent mechanism. This is in good agreement with a very recent publication demonstrating chlorpromazine sensitive uptake of mature and pro-BMP2 in C2C12 cells exposed to very high levels of unlabeled recombinant proteins (von Einem et al., 2011) .
Increased FL-BMP2 uptake requires active vesicular transport
Since clathrin mediated vesicle formation is the first step in further endosome/lysosome mediated recycling processes we also analyzed the effect of monensin on FL-BMP2 internalization (Fig. 8A) . Monensin is an ionophore, which changes vesicular acidification and such interferes with transport pathways and endosome/lysosome Journal of Cell Science Accepted manuscript 11 mediated transport and recycling processes (Mollenhauer et al., 1990) . Monensin had been used by Hartung et al. (2006) to demonstrate receptor recycling after endocytosis, which was efficiently blocked in the presences of monensin. Adding monensin in our experimental setting we observed a clear block of FL-BMP2 uptake at initial binding levels ( Fig. 8A) , which can be explained by internalization of ligand bound to receptors and binding sites present at the cell surface at the beginning of the experiment. Thus, the observed increased uptake of FL-BMP2 without monensin at later time points requires the generation of new free binding sites by recycling of cell surface receptors.
Disruption of lipid raft formation increases BMP2 uptake
Since genistein treatment did not show a significant difference of FL-BMP2 uptake at early time points of exposure, we also used nystatin to analyze the role of lipid raft formation and caveolin mediated processes on BMP2 internalization (Fig. 8B ). Nystatin interferes with lipid raft formation (Rothberg et al., 1992) and has been used to analyze the role of lipid rafts and caveolin mediated internalization in TGFβ-signaling (Di Guglielmo et al., 2003) . Co-incubation with nystatin significantly enhanced BMP2 uptake at early time points, at 1 and 3 h (Fig. 8B) . In contrast, no significant difference of FL-BMP2 uptake with and without nystatin could be observed at later time points, at 6 and 12 h. This suggests that lipid rafts associated receptors are not involved in BMP2 uptake.
In fact, disruption of lipid rafts by nystatin seems to make more BMP2 binding sites available for inclusion in clathrin coated pits increasing BMP2 uptake at early time points. Taken together, these results clearly establish clathrin mediated endocytosis as the major route for BMP2 internalization.
Discussion
Despite various studies on BMP-and TGFβ-receptor internalization, so far no detailed In fact, enzymatic inactivation of heparansulfates with heparinase III clearly reduced BMP2 endocytosis also in presence of Noggin, which is consistent with a co-receptor function or another key role in endosomal uptake (Fig. 6B) .
The delayed increase observed by co-incubation with dorsomorphin suggests that receptor activity is also important for receptor endocytosis, receptor recycling and de novo synthesis. In fact, treatment with the protein synthesis inhibitor cycloheximide (100 µM) reduced BMP2 internalization, but did not completely block the time dependent increase (data not shown) indicating that both, receptor recycling and de novo synthesis, are required for efficient BMP2 endocytosis at later time points. The importance of specific cell surface binding sites was also confirmed by the overexpression of BMPR1a, which led to a clear increase in BMP2 internalization.
Taken together our results clearly show, that BMP2 is internalized by a highly specific receptor dependent mechanism and sorted to late endosomal particles as intact protein. 
Materials and methods
Cell Culture
HeLa cells (ATCC) were cultured in Dulbecco's modified eagle medium (DMEM) (PAA, Pasching, Austria), supplemented with 10% FBS (PAA, Pasching, Austria), 1%
penicillin/streptomycin (Gibco, Invitrogen) in a CO 2 incubator at 37°C with 5% CO 2 .
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16 Stimulation with FL-BMP2 was performed in starvation medium after overnight serum deprivation with 400 ng/ml of protein for the times indicated. BMP2 antagonists were added together with FL-BMP2 as indicated. For treatment with heparinase III, cells were pre-incubated for 2 h with 0.5 U/ml of the enzyme before FL-BMP2 treatment. For transient over-expression HeLa cells were transfected with BMPR1a expression vector using Nanofectin (PAA, Pasching, Austria). 24 h post-transfection, medium with 10%
FCS was replaced by starvation medium and after overnight serum deprivation transfected and non-transfected cells were stimulated with 400 ng/ml FL-BMP2 and after 6 h of incubation FL-BMP2 uptake was analyzed by flow cytometry.
Single cell tissue culture preparation
HeLa cells were harvested from standard tissue culture. After cell counting, cells were washed once with 10% sucrose, and then resuspended in liquid RADA16 peptide, a generous gift from Shuguang Zhang, MIT Cambridge, USA, (0.25% w/v, sequence: Ac-RADARADARADARADACONH2). 200 µl cell suspensions were transferred to 24 well plates at final concentrations of 1,000,000 cells/ml. This cell concentration provides cell densities in three dimensions that are equivalent to a plating density of 10,000 cells/cm 2 .
The gel formation of peptide was started adding 400 µl of full tissue culture medium supplemented with 10% FCS (Semino et al., 2003) . In the first hour of growth in peptide matrix, medium was exchanged 3 times to avoid dramatic changes of pH. Before incubation in starvation medium, cells were incubated overnight in medium with 10% FCS, which was followed by overnight Incubation starvation medium. Subsequently, cells were stimulated with 400 ng/ml FL-BMP2 in starvation medium for time points indicated and collected by breaking the matrix just by several times repeated pipetting.
Cells were then directly analyzed by flow cytometry to analyze FL-BMP2 binding and uptake.
Recombinant proteins and reagents
Recombinant human BMP2 and Noggin were prepared by Peter Hortschansky, Jena, Germany. Recombinant proteins Gremlin and Chordin were purchased from R&D systems. Sources for other molecules were: dorsomorphin (Merck, Germany),
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chlorpromazine and heparinase III (Sigma Aldrich).
Cells were pre-incubated for 30 min with several small molecules including 10 µM chlorpromazine (Sigma-Aldrich) or/and 200 µM genistein (Sigma-Aldrich) before BMP2 treatment for selective inhibition of clathrin or caveolin dependent endocytosis, respectively. To study whether receptor recycling and de novo synthesis are required for efficient BMP2 endocytosis we used 10 µM monensin (Sigma-Aldrich) and a protein synthesis inhibitor, cycloheximide (Sigma-Aldrich) (100 µM) respectively. Treatment with 25 µg/ml nystatin (Sigma-Aldrich) was also employed to investigate caveolin mediated processes on BMP2 internalization.
Fluorescence labeling of BMP2 and purification of FL-BMP2
100 µg lyophilized recombinant human BMP2 was dissolved in 50 µl de-ionized water to obtain a final protein concentration of 2 mg/ml. Labeling buffer containing DyLight633
was freshly prepared at 2x concentration ( phospho-Smad1/5/8 specific antibody (R&D Systems, USA); BMPR1a (ALK3) specific antibody (Santa Cruz, Germany).
To analyse FL-BMP2 integrity after cellular uptake at indicated time points, cell lysates of HeLa cells treated with 400 ng/ml FL-BMP2, or co-incubated with Noggin (5× access), or PBS-washed after 1 h stimulation with FL-BMP2 were analyzed. Equal amounts of cell lysates were loaded on 15% SDS-PAGE. The gel was scanned using the 633 nm laser line in a Typhoon 9410 laser scanner (Amersham Biosciences) (Suppl. Fig.   1 ).
BRE-secretion assay
7×10
4 HeLa cells/well were cultured in 12 well plate. After 24 h cultivation, serum was removed and cells were kept overnight in starvation medium. Directly before transfection fresh starvation medium was added. Cells were transfected with 1.5 µg of plasmid preparation containing 0.9 µg pBRE-GLuc + 0.6 µg of control plasmid pSV40-CLuc using Nanofectin (PAA, Pasching, Austria).
40 h after transfection NL-BMP2 (100 ng/ml) and FL-BMP2 (50, 100 and 200 ng/ml) were added and 20 µL of supernatant were collected from each well at indicated time points. Activity of secreted luciferase was measured using the BioLux® Gaussia luciferase assay kit (New England Biolabs) according to manufacturer instructions using
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a Tecan Safire2 MT-plate reader (Tecan, Maennedorf, Switzerland).
Flow cytometry
To 
Image Segmentation and Parameter Extraction
Confocal microscopy images were segmented using a custom-made Java ImageJ plugin 
